HIGHLIGHTS
- What: The study assesses the antimicrobial and anti-biofilm effect of L acidophilus VB1 and its metabolites against CSOM-associated bacteria. The authors determined the MBIC50 of both La-CFS and La-BS, which is defined as the lowest concentration of an antimicrobial that inhibits ≥ 50% of biofilm formation compared to an untreated control (bacterial biofilm without antimicrobial treatment). The study showed that Lactobacillus acidophilus VB1 has the potential to auto-aggregate and co-aggregate with the tested bacterial pathogens.
- Who: Igor V. Popov et al. from the Department of Microbiology, Veterinary Medicine College, of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.